Studies from Institute of Hematology and Transfusion Medicine Update Current Data on Chronic Lymphocytic Leukemia (Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era ...)

MLA

“Studies from Institute of Hematology and Transfusion Medicine Update Current Data on Chronic Lymphocytic Leukemia (Efficacy of High-Dose Corticosteroid-Based Treatment for Chronic Lymphocytic Leukemia Patients with P53 Abnormalities in the Era ...).” Hematology Week, 27 July 2020, p. 1219. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.630595572&authtype=sso&custid=ns315887.

APA

Studies from Institute of Hematology and Transfusion Medicine Update Current Data on Chronic Lymphocytic Leukemia (Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era ...). (2020, July 27). Hematology Week, 1219.

Chicago

Hematology Week. 2020. “Studies from Institute of Hematology and Transfusion Medicine Update Current Data on Chronic Lymphocytic Leukemia (Efficacy of High-Dose Corticosteroid-Based Treatment for Chronic Lymphocytic Leukemia Patients with P53 Abnormalities in the Era ...),” July 27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.630595572&authtype=sso&custid=ns315887.